Northwest Capital Management’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$695K Buy
9,288
+961
+12% +$71.7K 3.01% 6
2025
Q3
$612K Buy
8,327
+576
+7% +$41.3K 0.64% 40
2025
Q2
$549K Sell
7,751
-341
-4% -$22.7K 0.3% 77
2025
Q1
$516K Buy
8,092
+4,678
+137% +$293K 0.21% 79
2024
Q4
$200K Buy
3,414
+43
+1% +$2.69K 0.09% 108
2024
Q3
$223K Buy
3,371
+40
+1% +$2.56K 0.08% 101
2024
Q2
$209K Sell
3,331
-421
-11% -$26.3K 0.08% 100
2024
Q1
$235K Buy
3,752
+38
+1% +$2.27K 0.08% 110
2023
Q4
$217K Sell
3,714
-1
-0% -$56 0.07% 111
2023
Q3
$202K Buy
3,715
+494
+15% +$27.9K 0.08% 108
2023
Q2
$184K Buy
+3,221
New +$182K 0.08% 113

Other funds holding JIRE

Northwest Capital Management's JIRE Position: Q4 2025 in Review

Northwest Capital Management increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 12% in Q4 2025, buying an estimated $71.7K and bringing the position to 9,288 shares worth $695K. The position accounts for 3.01% of the portfolio, ranked #6.

Northwest Capital Management first reported a position in JIRE in Q2 2023 and has held it in 11 quarters since. 312 funds tracked by Wall St. Rank hold JIRE as of Q4 2025.

  • Northwest Capital Management held 9,288 shares of JPMorgan International Research Enhanced Equity ETF worth $695K as of Q4 2025.
  • Northwest Capital Management bought 961 JPMorgan International Research Enhanced Equity ETF shares in Q4 2025, an estimated $71.7K.
  • JPMorgan International Research Enhanced Equity ETF made up 3.01% of Northwest Capital Management's portfolio in Q4 2025, its #6 holding.
  • Northwest Capital Management first reported a position in JPMorgan International Research Enhanced Equity ETF in Q2 2023 and has held it in 11 quarters since.
  • 312 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q4 2025.

Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.